BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260423T201125
CREATED:20260302T035935Z
LAST-MODIFIED:20260302T035935Z
UID:10000257-1792713600-1793145599@melanoma.org.au
SUMMARY:ESMO Congress
DESCRIPTION:The ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. Participants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives: \n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy\n\nLocation: IFEMA Madrid\, Madrid\, Spain \nKey Dates: \nEarly Registration Deadline: 22 July 2026 at 23:59 CEST\nAbstract Submission Deadline: 12 May 2026 at 21:00 CEST\nLate-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST\nConference Dates: 23 October 2026 – 27 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esmo-congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/ESMO_2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR